Pfrepper, C. Et Al. 2024. Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study. HAEMOPHILIA , vol.30, no.2 , 395-403.

Pfrepper, C., Radossi, P., Windyga, J., Kavakli, K., Schutgens, R., SARPER, N., ... Gu, J.(2024). Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study. HAEMOPHILIA , vol.30, no.2, 395-403.

Pfrepper, Christian Et Al. "Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study," HAEMOPHILIA , vol.30, no.2, 395-403, 2024

Pfrepper, Christian Et Al. "Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study." HAEMOPHILIA , vol.30, no.2, pp.395-403, 2024

Pfrepper, C. Et Al. (2024) . "Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study." HAEMOPHILIA , vol.30, no.2, pp.395-403.

@article{article, author={Christian Pfrepper Et Al. }, title={Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study}, journal={HAEMOPHILIA}, year=2024, pages={395-403} }